Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System

E-ISSN： 1873-5576|18|2|124-138

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.2, 2018-01, pp. : 124-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer-Targeted Polymeric Drugs

Current Cancer Drug Targets, Vol. 2, Iss. 3, 2002-09 ,pp. : 209-226

Bentham Science Publishers

Access to resources Recommend Favorite

Selectively Replicating Adenoviruses for Oncolytic Therapy

Current Cancer Drug Targets, Vol. 1, Iss. 2, 2001-08 ,pp. : 85-107

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted and Armed Oncolytic Poxviruses for Cancer: the Lead Example of JX-594

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 9, 2012-07 ,pp. : 1768-1772

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets

By Halldén Gunnel Portella Giuseppe

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 945-958

Informa Healthcare

Access to resources Recommend Favorite

Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 18, 2017-11 ,pp. : 1696-1712

Bentham Science Publishers

Access to resources Recommend Favorite